4//SEC Filing
BIOGEN INC. 4
Accession 0001127602-17-001434
$BIIBCIK 0000875045operating
Filed
Jan 9, 7:00 PM ET
Accepted
Jan 10, 4:15 PM ET
Size
8.3 KB
Accession
0001127602-17-001434
Insider Transaction Report
Form 4
BIOGEN INC.BIIB
PANGIA ROBERT W
Director
Transactions
- Sale
Common Stock
2017-01-09$295.39/sh−5,450$1,609,876→ 16,628 total - Exercise/Conversion
Stock Option (Right to Buy)
2017-01-09−5,450→ 0 totalExercise: $52.22Exp: 2017-05-30→ Common Stock (5,450 underlying) - Exercise/Conversion
Common Stock
2017-01-09$52.22/sh+5,450$284,599→ 22,078 total
Footnotes (2)
- [F1]Exercise/sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.
- [F2]Options will become 100% exercisable upon completion of one year of service with Biogen Idec Inc.
Documents
Issuer
BIOGEN INC.
CIK 0000875045
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0000875045
Filing Metadata
- Form type
- 4
- Filed
- Jan 9, 7:00 PM ET
- Accepted
- Jan 10, 4:15 PM ET
- Size
- 8.3 KB